Author name: José Martín Palomo

Integrated treatment for patients with comorbid depression and personality disorders

We advocate considering depression and personality as being more closely related and argue in favour of the development of integrated treatment options tailored to understanding symptoms as being interwoven with a variety of long-standing disturbing personality patterns. Both clinically and conceptually, psychodynamic and schema-focused approaches provide good opportunities to adjust available therapies and they could […]

Integrated treatment for patients with comorbid depression and personality disorders Read More »

Inflammation and depression but where does the inflammation come from?

The advent of innovative theories about the pathophysiology of psychiatric disorders has ushered in a new era on the basis of the role of the immune system and inflammation in mediating depression in its multifaceted manifestations. Extensive studies have confirmed the proinflammatory status in depression and causal relationships with neurotransmitter dysregulation. Equally importantly the role

Inflammation and depression but where does the inflammation come from? Read More »

Neurofilament light protein as a biomarker in depression and cognitive function

Axonal damage is implicated in the neuropathology of depression and cognitive dysfunction. Consequently, neurofilament light protein is an emerging biomarker with potential in depression and cognitive function. Results are more consistent for cognition, requiring more research to assess neurofilament light protein in depression as well as other psychiatric disorders. Future longitudinal studies are necessary to

Neurofilament light protein as a biomarker in depression and cognitive function Read More »

Promoting physical activity for mental health: an updated evidence review and practical guide

Translation of evidence regarding physical activity for mental health into routine programmes is critical. Efforts to move beyond solely targeting individual-level barriers to physical activity and address systemic barriers include lack of access to appropriate exercise services. This requires consideration of training needs, service structure and culture change. Leer texto completo

Promoting physical activity for mental health: an updated evidence review and practical guide Read More »

Reward processing dysfunction in major depression, bipolar disorder and schizophrenia

New evidence of reward processing abnormalities in MDD, bipolar disorder and schizophrenia has led to a greater understanding of the neural processes associated with symptomatology common across these conditions (e.g., anhedonia). Dissecting various subcomponents of reward processing that map onto partially different neurobiological pathways and investigating their dysregulation in different psychiatric disorders holds promise for

Reward processing dysfunction in major depression, bipolar disorder and schizophrenia Read More »

Neurostimulation as a treatment for mood disorders in patients: recent findings

Brain stimulation is widely used in clinical settings; however, there is a lack of understanding about its neurobiological mechanism. Further studies are needed to understand the neurobiology of brain stimulation and how it can be used to treat mood disorders in their diversity, including comorbidities with other illnesses. Leer texto completo

Neurostimulation as a treatment for mood disorders in patients: recent findings Read More »

Cardiovascular disease risk in people with severe mental disorders: an update and call for action

The level of CVD comorbidity remains high in SMDs, indicating that most people with SMDs have not benefitted from recent medical advances. A complex interplay between genetic and social vulnerability to CVD, which differs across subgroups of patients, seems to be involved. Further research is required to meet the urgent need for earlier, more efficient

Cardiovascular disease risk in people with severe mental disorders: an update and call for action Read More »

Recent advances in noninvasive brain stimulation for schizophrenia

Using brain stimulation to treat symptoms of schizophrenia seems promising and the great flexibility of the stimulation parameters leaves much room for developing optimization strategies and improving its effectiveness. Further studies need to identify the optimal parameters to maximize response rate. Leer texto completo

Recent advances in noninvasive brain stimulation for schizophrenia Read More »

Brain vasculature disturbance in schizophrenia

In some patients with SZ, a vulnerable brain endothelium may be interacting with environmental stressors, such as inflammation or hypoxia, converging into a more severe SZ symptomatology. Gene expression and performance of human brain endothelium could vary along with development and the establishment of the BBB; therefore, we encourage to investigate its possible contribution to

Brain vasculature disturbance in schizophrenia Read More »

Depression: more treatment but no drop in prevalence: how effective is treatment? And can we do better?

To reduce prevalence, it is essential to narrow the treatment gaps, provide timely interventions and high- quality treatment, eradicate waiting lists, prescribe antidepressants more cautiously and better managed, consider psychological alternatives, and provide more psychosocial treatment in primary care with physician-assistants. In addition, research is needed on long-term outcome of different treatment modalities, and least

Depression: more treatment but no drop in prevalence: how effective is treatment? And can we do better? Read More »

3er Simposio Psiquiatría Octubre 2023

https://luyelearning.com/wp-content/uploads/2023/03/3er-simposio.mp4 ESPERA NUESTRA SIGUIENTE EDICIÓN DONDE PODRÁS ESCUCHAR Y APRENDER SOBRE EL TRATAMIENTO DE TRASTORNOS MENTALES, TERAPIA COGNITIVO-CONDUCTUAL, LAS ÚLTIMAS INVESTIGACIONES EN PSIQUIATRÍA, ENTRE OTROS TEMAS RELEVANTES. ADEMÁS DE UN FORO DE DISCUSIÓN EN LÍNEA PARA QUE LOS PARTICIPANTES PUEDAN HACER PREGUNTAS Y DISCUTIR TEMAS CON LOS PONENTES Y CON OTROS PARTICIPANTES.

3er Simposio Psiquiatría Octubre 2023 Read More »